Today in trading, shares of Hls Therapeutics Inc opened at $4.65 and closed at $4.65. It traded at a low of $4.65 to a high of $4.66.

Shares $verbed percentage_change% from the previous day's close of $4.65.

During the day across North America, the TSX Composite closed 0.06% at 21728.55, the S&P 500 closed -0.34% at 5018.39, the Dow Jones Industrial Average closed 0.23% at 37903.29 and the Nasdaq Composite closed -0.33% at 15605.48.

Hls Therapeutics Inc has listed on the Toronto Stock Exchange (TSX) under the ticker HLS.

Trading volume was 468 on 5 total trades, with an average volume of 2,916 over 5 days.

The TSX overall saw 3,697 price advancers against 1,526 declines and 95 unchanged.

During the prior 52 weeks, HLS.TO has traded as high as $7.12 (July 17,2023) and low as $3.34 (November 27,2023). Moreover, in the last 12 months, Hls Therapeutics Inc's shares have eased -16.37 percent, while in 2024, they have boosted 17.72%.

It announced a 0.05 dividend on March 15/23, with an April 27/23 ex-date and June 15/23 pay day.

Following today's trading, Hls Therapeutics Inc has a market capitalization of $148.27 million on a float of 31,886 shares outstanding. Its annual EPS is $-0.85.

Hls Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Etobicoke, CAN.

Hls Therapeutics Inc is holding an average recommendation of "Moderate Buy" from 5.00 analysts according to Zacks. Currently, there are 3 buy ratings and 2 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..